Danaher Corp (DHR) stock saw a modest uptick, ending the day at $244.11 which represents a slight increase of $5.75 or 2.41% from the prior close of $238.36. The stock opened at $239.61 and touched a ...

Danaher Corp. closed 13.34% below its 52-week high of $281.70, which the company reached on August 1st.

Danaher (DHR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...

Danaher Corp (DHR) stock saw a decline, ending the day at $238.36 which represents a decrease of $-3.54 or -1.46% from the prior close of $241.9. The stock opened at $242.17 and touched a low of $238.

Danaher executed a $4.5 billion share buyback, with an additional 20 million shares authorized. Learn why I remain bullish on ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

LVW Advisors LLC trimmed its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 28.6% in the 4th quarter, Holdings ...

Arkadios Wealth Advisors trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 6.1% in the 4th quarter, ...

Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker immunoassays designed to advance ...

In a report released today, Luke Sergott from Barclays maintained a Hold rating on Danaher (DHR – Research Report), with a price target of ...

Innovaccer on Thursday announced separately that it has closed a $275 million Series F funding round that includes participation from Danaher Ventures and others.

Shares of Danaher Corp. DHR advanced 1.65% to $241.90 Thursday, on what proved to be an all-around dismal trading session for ...